How Europe is building a sweeping system to study medication safety in pregnant and lactating women

More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
Source: FRED DUFOUR/AFP/Getty Images

Drug companies, politicians, hospitals, doctors, and patients all agree that there isn’t nearly enough information about whether a given medicine is safe for pregnant and breastfeeding women to use or whether it will work.

A sweeping new effort in Europe aims to change that by bringing all of those groups together to address a public health issue they say demands urgent attention.

The project, dubbed ConcePTION, is a $32 million effort from the Innovative Medicines Initiative, a public-private partnership between the drug industry and the European Commission, the executive branch of the European Union. There are more than 200 researchers and 88 organizations involved in ConcePTION, which is being

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readScience
Opinion: Predicting Immunotherapy Success: We’ve Mastered The Foothills But The Summit Lies Ahead
Every increment of progress in immunotherapy is important, but our understanding of the massively complex human immune system remains incomplete.
STAT6 min readSociety
Opinion: A Deficit Of More Than 250,000 Public Health Workers Is No Way To Fight Covid-19
What happens when a nation systematically cuts or underfunds its public health workforce? We are seeing an answer to that in the response to the #Covid19 pandemic sweeping across the…
STAT3 min readScience
GlaxoSmithKline And Vir Aim To Take On Covid-19 With Antibodies And CRISPR
The drug giant GlaxoSmithKline is collaborating with Vir Biotechnology on experimental treatments and potentially, vaccines against the novel coronavirus.